Xueba’s medical black technology system

Chapter 155 Isn’t this insulting?
Institute of Drug Research.

Lu Liang sat down on the sofa in Chen Shen's office, but it was different from the previous times.

This time besides Lu Liang, there were three other people here.

The three people were two men and one woman. They sat down opposite Lu Liang. The leader was a middle-aged man with a slicked back hair and wearing a cadre uniform.

In comparison, the other two are relatively young.

Chen Xi brought several glasses of water with disposable cups and placed them in front of several people. Then he introduced to Lu Liang: "Xiao Lu, these are staff from the Food and Drug Administration."

Someone from the Food and Drug Administration?

Lu Liang was slightly surprised.

After introducing Lu Liang, Chen Shen turned to introduce to the three of them: "This is the assistant researcher of our Drug Research Institute, Lu Liang."

After hearing Chen Shen's introduction, the eyes of the leading middle-aged man suddenly lit up, and a smile suddenly appeared on his face: "So it's you who is Researcher Lu. You are indeed a hero from a young age. I have admired you for a long time."

The middle-aged man said while extending his hand in a friendly manner.

Lu Liang also quickly put down his cup, then stood up and shook hands with the middle-aged man.

Then, Lu Liang looked at Chen Shen and said, "Director Chen, what is that important thing you mentioned?"

Chen Shen answered: "This time it is the Food and Drug Administration who is looking for you. They want to ask you for a favor."

really.

In fact, after learning that the three people were staff of the Food and Drug Administration, Lu Liang roughly guessed that this important matter might be related to the Food and Drug Administration.

But what the specific matter was, Lu Liang didn't know.

"Director Chen, let me do the talking." The middle-aged man named the leader said with a smile.

Chen Shen nodded and made a "please" gesture.

After getting Chen Shen's permission, the middle-aged man looked at Lu Liang with a smile and said, "Let me introduce myself first. My name is Xu Shoulin. I am here to see you, Researcher Lu, mainly because of a drug."

"Speaking of this drug, it has something to do with you, Researcher Lu." Xu Shoulin said.

"What medicine?" Lu Liang asked curiously.

Xu Shoulin paused and replied: "Anti-lung cancer drug, sugemalimab."

This made Lu Liang frown.

Isn’t sugalimab a drug from Moco? What does it have to do with me?
Seemingly sensing Lu Liangliang's confusion, Xu Shoulin continued: "Researcher Lu, you should have read the two interview reports about the drug sugalimab, right?"

"Two articles, not one?"

Lu Liang was a little confused. In his impression, the report was written by a reporter named Tan Ting. He also commented under the report at that time.

"Later, they published another article, and it was a report specifically published in response to your comment, Researcher Lu." Xu Shoulin explained to Lu Liang.

Lu Liang nodded slowly, and then he couldn't help but ask: "So, what are the specific problems you mentioned?"

Xu Shoulin replied: "Researcher Lu, you should know that in China, advertising of prescription drugs is prohibited. This is a legal requirement."

Lu Liang nodded, he could understand this.

After all, if the promotion of prescription drugs is allowed, given the character of those pharmaceutical companies, they will definitely do whatever they can to promote their own drugs and brag about their drugs to the sky.And medicine is a field with a relatively high knowledge threshold. If a patient is brainwashed by these advertisements and does not follow the doctor's instructions, but chooses to buy his own medicine and take it, who will be responsible for any problems with the medicine.

After all, those are prescription drugs.

At this moment, Xu Shoulin said the key to the problem: "The two reports on sugalimab are obviously advertising."

"The first time they were able to hold a press conference, we just turned a blind eye and ignored it, but their second report went too far!"

After listening to Xu Shoulin's words, Lu Liang realized the seriousness of the problem.

Indeed, if this kind of behavior is not stopped, other pharmaceutical companies will definitely follow suit and find people to report on their own drugs.

However, Lu Liang felt something strange.

Since the drug sugalimab is suspected of being a prescription drug advertisement, it stands to reason that the people from the Food and Drug Administration should go to Moco. Why go to you?

Is there anything else I can do to help?

Lu Liang looked at Xu Shoulin doubtfully: "Then you go directly to Moco Company and temporarily remove their drugs from the shelves. Wouldn't it be better?"

Xu Shoulin shook his head: "The problem arises here. The drug Shugli is indeed suspected of advertising and violates regulations, but we have to admit that this drug is indeed the best drug for the treatment of lung cancer at present."

At this point, Xu Shoulin paused and did not continue.

But even so, Lu Liang instantly understood what Xu Shoulin meant.

Although the price of sugalimab is very expensive.

But it is undeniable that some lung cancer patients who have no available drugs can only rely on the drug sugalimab to survive.

If sugemalimab is removed from the shelves due to advertising issues at this time, this action will almost cut off the last way of life for lung cancer patients.

But if some measures are not taken, other pharmaceutical companies will imitate Moco's operation, and the situation will be chaotic.

After Lu Liang thought for a moment, he looked at Xu Shoulin and asked, "So, the purpose of you looking for me is to help me develop anti-lung cancer drugs as soon as possible?"

Xu Shoulin hesitated for a while, and finally he could only smile helplessly: "There is nothing we can do about this. If we can't find a better drug than sugalimab, we will be constrained everywhere."

"So, the only thing we can think of is you, Researcher Lu."

After all, Lu Liang once replied to Tan Ting's report that he was already working on anti-lung cancer drugs.

Then, Xu Shoulin seemed to have thought of something, and he quickly said: "Of course, I don't mean to make the therapeutic effect of the new drug completely reach the level of sugalimab, or even replace sugalimab."

"I know that it is very difficult to achieve this step. Therefore, the efficacy of the drug only needs to be about [-]% of the efficacy of sugalimab and can play a similar role."

After all, he had also read the second report sent by Tan Ting. In that report, the female doctor's speech was too confident, and the female doctor's identity was blessing.

Xu Shoulin subconsciously felt that the drug developed by Lu Liang might not be as good as sugalimab.

But even the efficacy is really not as good as sugemalimab.

But achieving similar effects is not a big problem, right?
Xu Shoulin thought in his mind while looking at Lu Liang with vague expectation.

He knew all the miracles the young man in front of him had created before, so this also made Xu Shoulin have an inexplicable expectation for the young man in front of him.

However, under everyone's expectant gazes, Lu Liang just shook his head.

　The titles of chapters 78 and 79 were reversed. The review was stuck and they haven’t been corrected yet.
　　
　
(End of this chapter)